TABLE 4.
Parameter | Hazard ratio | 95% CI | P |
---|---|---|---|
Age | 1.376 | 1.286–1.475 | <0.0001 |
Female gender | 1.129 | 0.936–1.359 | 0.203 |
Raceb | |||
Black | 1.223 | 0.991–1.501 | 0.058 |
Other | 0.804 | 0.485–1.253 | 0.366 |
Pseudomonas aeruginosa BSI | 1.435 | 1.043–1.933 | 0.021 |
APACHE-II chronic health score | 1.168 | 1.101–1.244 | <0.0001 |
MDR | 1.051 | 0.869–1.269 | 0.609 |
Appropriate antibiotic therapyc | 1.435 | 0.967–2.202 | 0.085 |
Days to line removald | |||
1 | 0.537 | 0.192–1.305 | 0.194 |
2 | 0.606 | 0.232–1.424 | 0.271 |
≥3 | 0.904 | 0.259–2.468 | 0.857 |
No line-associated infection | 7.227 | 0.392–37.881 | 0.060 |
BSI era (2005-2015)e | 2.581 | 1.863–3.690 | <0.0001 |
BSI sourcef | |||
Biliary | 0.607 | 0.303–1.105 | 0.127 |
Pneumonia | 2.264 | 1.628–3.169 | <0.0001 |
Line | 5.411 | 0.299–26.650 | 0.103 |
Skin/soft tissue | 0.531 | 0.322–0.847 | 0.010 |
Abscess | 0.721 | 0.387–1.254 | 0.273 |
Other | 1.035 | 0.726–1.476 | 0.850 |
Source not identified | 2.073 | 1.549–2.810 | <0.0001 |
Abbreviations: BSI, bloodstream infection; CI, confidence interval; MDR, multidrug resistant. Statistically significant values are indicated in boldface.
The reference group was composed of white patients.
This is a time-dependent variable in which “no appropriate antibiotic therapy” is the reference.
The reference group is composed of patients with line-associated infections and line removal on day 0.
The reference group is composed of BSI from 2002 to 2004.
The reference group is BSI from a urine/pyelonephritis source.